Wound Dressing with Electrostatic Antimicrobial Retention

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current wound dressings for moist or wet wounds have limited duration of use, requiring frequent changes which can interfere with wound healing and are prone to recontamination due to the absence of antimicrobial substances.

Innovation Solution

A wound dressing with a cationic antimicrobially acting substance that binds to anionic superabsorbent material, preventing its entry into the wound, combined with a structured, atraumatically acting coating on the wound-facing side to enhance liquid exchange and prevent adhesion, extending the dressing's use time without recontamination.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If frequent bandage changes are performed to maintain wound conditioning, then wound healing is supported, but productivity decreases and interference with wound healing increases

Engineering Contradiction:
Improvewound conditioningVSAvoidtime interval for changing
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent applies preliminary action by incorporating antimicrobial substances into the wound dressing before use. These substances are pre-positioned in the dressing material to actively prevent bacterial growth throughout the extended wear period, eliminating the need for frequent changes to maintain wound conditioning.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The wound dressing performs self-service by automatically maintaining antimicrobial protection through the slow release of antimicrobial substances from the dressing material. This self-sustaining mechanism continues to protect the wound without requiring external intervention or frequent replacement.

Inventive Principle:
Principle #25Self-service

2Object-affected harmful factors

If antimicrobial substances are added to the wound dressing, then recontamination is prevented, but the substances may enter the wound and cause harm

Engineering Contradiction:
ImproverecontaminationVSAvoidantimicrobial substance entry
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent uses the superabsorbent material as an intermediary substance that binds to and retains the antimicrobial substances. This intermediary mechanism allows the antimicrobial agents to remain contained within the dressing while still providing protection, preventing both recontamination and direct harm to the wound.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent applies parameter changes by controlling the release characteristics of antimicrobial substances through the superabsorbent material matrix. The substance release is regulated to occur slowly and controllably, changing the delivery parameter from immediate release to sustained release over the dressing wear period.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If the wound dressing is used for extended periods, then productivity increases, but the risk of recontamination increases

Engineering Contradiction:
Improvetime interval for changingVSAvoidrecontamination risk
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent ensures continuity of useful action by incorporating antimicrobial substances that continuously protect the wound throughout the extended wear period. The slow release mechanism maintains active antimicrobial protection from the first hour through the entire dressing wear time, eliminating recontamination risk regardless of duration.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution allows for extended use of the wound dressing beyond 24 hours, maintaining an optimally antimicrobially conditioned wound milieu, reducing recontamination risks, and improving wound healing by enhancing liquid exchange and retention of antimicrobial substances within the dressing.

Implementation Method 1

a cationic antimicrobially acting substance which is cationic at pH values of 4-7.5 of a typical moist or wet wound milieu and is attracted by the negative groups of the anionic superabsorbent material and in this way acts antimicrobially inside the suction/rinse body

Methodology Applied
Scientific EffectElectrostatic attraction: Ion Repulsion/Attraction

Implementation Method 2

a fibrous nonwoven fabric based suction/rinsing body in which super absorbent material is distributed, wherein the suction/rinsing body is supplied by the manufacturer with a saline aqueous solution

Methodology Applied
Scientific EffectAbsorption: Absorption (physical)

Implementation Method 3

on the side of the suction/rinsing body which faces away from the wound, an evaporation-inhibiting film layer can be provided

Methodology Applied
Scientific EffectEvaporation inhibition: Evaporation

Data Source

PatentUS9050443B2Wound dressing
Publication Date: 2015.06.09 IVF HARTMANN AG
  • US9050443B2 patent drawing
  • US9050443B2 patent drawing
  • US9050443B2 patent drawing

AI summary

A wound dressing for wound treatment in a moist or wet milieu includes a fibrous non woven fabric-based suction-/rinsing body, a superabsorbent material distributed in the suction-/rinsing body and including negative groups, a saline aqueous solution including an antimicrobially acting substance which is cationic at pH values of 4-7.5 of the moist or wet milieu, wherein the antimicrobially acting substance is attracted and retained by the negative groups of the superabsorbent material, and is supplied to the suction-/rinsing body by the manufacturer, and a cover forming outer visible sides of the wound dressing, wherein an atraumatically acting coating is applied in some regions and in a structured manner on one of the outer visible sides which faces toward the wound, with a degree of coverage of at most 70%.